This CME has expired. The Forum: A Working Group for Women's Healthcare Vol. 6, No. 4 Ovarian Cancer Risk Reduction Through Pharmacologic, Surgical, and Lifestyle Interventions Overview of Eating Disorders Update on Medical Abortion Release Date: August 2008 Expiration Date: August 31, 2010 EDITOR-IN-CHIEF Lee P. Shulman, MD Anna Ross Lapham Professor & Chief, Division of Reproductive Genetics Department of Obstetrics & Gynecology Medical Director, Graduate Program in Genetic Counseling Co-Director, Northwestern Ovarian Cancer Early Detection and Prevention Program Feinberg School of Medicine of Northwestern University Chicago, IL EDITORIAL BOARD Raquel D. Arias, MD Associate Dean of Women Associate Professor, Obstetrics and Gynecology Clinical Associate Professor of Gerontology University of Southern California Los Angeles, CA Sarah L. Berga, MD James Robert McCord Professor and Chair Department of Gynecology & Obstetrics Emory University School of Medicine Atlanta, GA Ellen Hirschman Miller, MD Clinical Assistant Professor of Medicine Albert Einstein College of Medicine Bronx, NY Vice President of Academic Affairs Southside Hospital Bay Shore, NY Anita L. Nelson, MD Professor Department of Obstetrics & Gynecology David Geffen School of Medicine at UCLA Medical Director, Women’s Health Care Programs Harbor-UCLA Medical Center Manhattan Beach, CA Teri Pearlstein, MD Director Women’s Behavioral Health Women and Infants Hospital Providence, RI Owen P. Phillips, MD Professor Associate Chair, Department of Obstetrics & Gynecology University of Tennessee at Memphis Memphis, TN Patricia J. Sulak, MD Director Division of Ambulatory Care & Women’s Health Care Research Program Scott & White Hospital Temple, TX Sharon A. Winer, MD, MPH Clinical Professor of Obstetrics and Gynecology and Reproductive Bioendocrinology University of Southern California Keck School of Medicine Los Angeles, CA Susan Wysocki, RNC, NP, FAANP President and CEO National Association of Nurse Practitioners in Women’s Health Washington, DC GUEST AUTHOR Mandy Gittler,MD Medical Director All Women's Health Tacoma,WA, and Chicago, IL Clinical Faculty Pritzker School of Medicine, University of Chicago Feinberg School of Medicine of Northwestern University Chicago, IL EDITORS/MEDICAL WRITERS Jill Rovitzky Black Amanda Bach Stacy DiLoreto Faith Frankel Statement of Need: Clinicians who provide healthcare for reproductive- aged and menopausal women are faced with continual change that affects the way in which they practice.Among these changes are new and emerging means of family planning, including an increased understanding of noncontraceptive benefits associated with some contraceptives and a growing awareness of the importance of prepregnancy planning. In addition, practitioners are challenged with staying up to date on the medical literature regarding the comprehensive health needs of women. Demographic trends, such as an aging and increasingly overweight population and advanced maternal age, make it particularly challenging, and crucial, for clinicians to stay abreast of the latest developments in women’s health—with emphasis on preventive strategies, new diagnostic tests and screening recommendations, and treatment not only for conditions directly related to reproduction and menopause but for chronic disorders, such as diabetes, thyroid dysfunction, and cardiovascular disease, that become more prevalent with age. Intended Audience: This program has been developed for obstetrician/gynecologists, family physicians, nurse practitioners, and other healthcare providers involved in women’s health. Content: This program provides current information about pharmacologic, surgical, and lifestyle interventions that may reduce risk for ovarian cancer, and reviews the most common types of eating disorders, their medical consequences, and the range of strategies that are used to treat them. It also reports on current protocols for medical abortion. Learning Objectives: After participating in this activity, clinicians should be better able to: Describe 3 strategies that are associated with reduced risk for ovarian cancer. List 4 medical complications of anorexia nervosa and/or bulimia nervosa. Name 3 drug regimens employed in medical abortion. Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Dannemiller Memorial Educational Foundation and Haymarket Medical Education LP. The Dannemiller Memorial Educational Foundation is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Statement: The Dannemiller Memorial Educational Foundation designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s),TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health for 1.50 contact hour of continuing education credit, including 1.50 contact hours of pharmacology content. Method of Participation: This activity should take approximately 1 hour to complete. The participant should read the objectives, read the newsletter, take the post-test, complete the registration, and complete the evaluation form. The evaluation form provides each participant the opportunity to comment on the extent to which educational objectives were met, the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias, and his or her views on future educational needs. This credit is valid through August 31, 2010. No credit will be given after that date. If you have questions, you can contact Robyn Brown at robynb@dannemiller.com. Faculty Disclosures: In accordance with the Accreditation Council for Continuing Medical Education (ACCME), the Dannemiller Memorial Educational Foundation requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships he or she has with a commercial interest. Accordingly: Lee P. Shulman, MD, reports that he is on the speakers’ bureaus of Barr Laboratories/Duramed, Bayer HealthCare Pharmaceuticals, GlaxoSmithKline, Organon, Ortho, Roche, and Wyeth. Dr. Shulman is also on the advisory board of Barr Laboratories/Duramed, Bayer HealthCare Pharmaceuticals, Organon, and Ortho and is an investigator for Barr Laboratories/Duramed and Wyeth. Raquel D. Arias, MD, reports that she is on the speakers’ bureaus of and is a consultant or advisory board member for Bayer HealthCare Pharmaceuticals, Barr Laboratories/Duramed, Organon USA, Ortho-McNeil Pharmaceutical, Inc., and Wyeth. Sarah L. Berga, MD, reports that she is on the speakers’ bureaus of Ascend Therapeutics Inc., Merck Serono, and Novogyne Pharmaceuticals. She is also a consultant to QuatRx Pharmaceuticals Company, Upsher-Smith Laboratories Inc., and Wyeth. Mandy Gittler, MD, reports that she is on the speakers’ bureau of Duramed. Ellen Hirschman Miller, MD, reports that she is on the speakers’ bureaus of GlaxoSmithKline, Merck & Co., Inc., and Roche. Anita L. Nelson, MD, reports that she is on the speakers’ bureaus of Barr Laboratories/Duramed, Bayer HealthCare Pharmaceuticals, Digene Corporation, Esprit Pharma Inc., Merck & Co., Inc, Organon, TherRx, and Wyeth. Dr. Nelson is on the advisory boards of Barr Laboratories/Duramed, Bayer HealthCare Pharmaceuticals, Organon, and Wyeth, and is an investigator for Barr Laboratories/Duramed, Bayer HealthCare Pharmaceuticals, and Wyeth. Teri Pearlstein, MD, reports that she received research support from Pfizer Inc. She and her spouse/partner are stockholders of Teva Pharmaceuticals. Owen P. Philips, MD, reports that she is on the advisory board of Merck & Co., Inc. Patricia J. Sulak, MD, reports that she is on the speakers’ bureaus of Barr Laboratories/Duramed, Bayer HealthCare Pharmaceuticals, Warner Chilcott, and Wyeth. Dr. Sulak is also on the advisory boards of Barr Laboratories/Duramed, Bayer HealthCare Pharmaceuticals, and Warner Chilcott and is an investigator for Barr Laboratories/Duramed, Organon, and Warner Chilcott. Sharon A. Winer, MD, MPH, reports that she is on the speakers’ bureaus of Bayer HealthCare Pharmaceuticals and Organon and is on the advisory board of Bayer HealthCare Pharmaceuticals. Susan Wysocki, WHNP-BC, NP, FAANP, reports that she is on the speakers’ bureaus and advisory boards of Barr Laboratories/Duramed, Bayer HealthCare Pharmaceuticals, Merck, Organon, and Wyeth. Ms. Wysocki is also on the advisory boards of Ortho Women’s Health, Digene Corporation, and Eli Lilly and Company. The Dannemiller and Haymarket Medical Education LP staff members who were involved in the development of this activity have no financial relationships with any commercial interests that are relevant to this activity. To resolve identified conflicts of interest, the educational content was fully peer reviewed by a physician member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced. Off-label Discussion: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. Disclaimer: The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of the Dannemiller Memorial Educational Foundation, the National Association of Nurse Practitioners in Women’s Health, Bayer HealthCare Pharmaceuticals, or Haymarket Medical Education LP. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.